Technical Analysis for KZR - Kezar Life Sciences, Inc.

Grade Last Price % Change Price Change
grade F 2.95 2.08% 0.06
KZR closed up 2.08 percent on Monday, November 11, 2019, on 1.22 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical KZR trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 2.08%
Lower Bollinger Band Walk Weakness 2.08%
Earnings Movers Other 2.08%
Inside Day Range Contraction 2.08%
Oversold Stochastic Weakness 2.08%

Older signals for KZR ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators
KZR Chart by TradingView
Basic chart:
Profile
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer.
Biotechnology Cancer Life Sciences Pharmaceutical Companies
Is KZR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Nov 10 The Week Ahead In Biotech: Adcom Test For Amarin's Fish Oil Pill, Agile Awaits FDA Verdict
Nov 8 Kezar Life Sciences to Host Conference Call and Webcast during the American College of Rheumatology Annual Meeting to Discuss Updated Results with KZR-616
Nov 6 Kezar Life Sciences EPS beats by $0.03
Nov 6 Kezar Life Sciences Reports Third Quarter 2019 Financial Results and Provides Business Update
Oct 28 Kaskela Law LLC Announces Investigation of Kezar Life Sciences, Inc. (KZR) on Behalf of Investors
Oct 1 Kezar Life Sciences Announces Presentations of Four Abstracts at the 2019 ACR/ARP Annual Meeting
Sep 27 Kezar Life Sciences to Present at the 2019 Cantor Global Healthcare Conference
Sep 16 Kezar Life Sciences (KZR) Investor Presentation - Slideshow
Sep 4 10 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Sep 3 65 Biggest Movers From Friday
See more KZR news...
Indicators
Indicator Value
52 Week High 36.33
52 Week Low 2.74
Average Volume 98,714
200-Day Moving Average 10.9816
50-Day Moving Average 3.3184
20-Day Moving Average 3.295
10-Day Moving Average 3.127
Average True Range 0.3608
ADX 13.51
+DI 19.0481
-DI 14.6964
Chandelier Exit (Long, 3 ATRs ) 2.7528
Chandelier Exit (Short, 3 ATRs ) 3.8224
Upper Bollinger Band 3.8048
Lower Bollinger Band 2.7852
Percent B (%b) 0.16
BandWidth 30.943854
MACD Line -0.136
MACD Signal Line -0.0938
MACD Histogram -0.0422
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.51
Resistance 3 (R3) 3.55 3.40 3.41
Resistance 2 (R2) 3.40 3.26 3.38 3.38
Resistance 1 (R1) 3.18 3.17 3.29 3.14 3.35
Pivot Point 3.03 3.03 3.09 3.01 3.03
Support 1 (S1) 2.81 2.89 2.92 2.77 2.55
Support 2 (S2) 2.66 2.80 2.64 2.52
Support 3 (S3) 2.44 2.66 2.49
Support 4 (S4) 2.40